Mara G. Coyle
Neonatologist • Associate Professor, The Warren Alpert Medical School of Brown University
MD, Dartmouth-Brown Program in Medicine, 1986
Dr. Coyle is a staff neonatologist at Women & Infants Hospital, the director of the Level II Nursery at St. Luke’s Hospital in New Bedford Massachusetts, and a professor of pediatrics (Clinical) at The Warren Alpert Medical School of Brown University. The ability to practice clinical medicine within the context of an academic center has afforded Dr. Coyle the opportunity to teach, explore clinical research opportunities, represent her institution in state organizations and industry, and most importantly, care for patients in an environment where clinical excellence is the expectation. Dr. Coyle’s research interest is in understanding the optimal treatment for opioid dependence in pregnancy and she has published multiple articles in the field, as well as lectured nationally.
Dr. Coyle has been a member of the Massachusetts Perinatal Advisory Committee since 2005 and helped write the state guideline for the substance-exposed newborn. Dr. Coyle serves on multiple hospital committees including her present position as chair of the Bioethics committee. In addition, she serves on a Pregnancy Registry Advisory Committee through TEVA pharmaceuticals and is a consultant for SmithGlaxoKline. Dr. Coyle received her undergraduate degree in Biology from Boston College, and her medical degree from the joint program at Dartmouth and Brown Medical Schools. She completed her pediatric residency training at the Children’s Hospital of Philadelphia, and her neonatal fellowship at Women & Infants Hospital in Rhode Island.
- Jones HE, Kaltenbach K, Heil SH, Stine SM, Coyle MG, Arria AM, O’Grady KE, Selby P, Martin PR, Fischer G. Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure. N Engl J Med 2010;2320-31.
- Coyle MG, Salisbury AL, Lester BM, Jones HE, Lin H, Graf-Rohrmeister K, Fisher G. Neonatal Neurobehavior Effects following Buprenorphine versus Methadone Exposure. Addiction.2012;107(suppl 1):63-73.
- Salisbury AL, Coyle MG, O’Grady KE, Heil SH, Martin PR, Stine SM, Kaltenbach K, Weninger M, Jones HE. Fetal Assessment before and after dosing with Buprenorphine or Methadone. Addiction. 2012;107(suppl 1):36-44.
- Bier JB, Finger A, Bier BA, Johnson T, Coyle MG. Growth and Developmental Outcome of Infants with In-Utero Exposure to Methadone vs. Buprenorphine. J Perinatol; (2 April 2015) doi:10.1038/jp.2015.22